Lastly, comorbidities like depression and cardiac abnormalities can influence platelet activation, thus platelet reactivity, assessed by examining platelet factor 4 and or P‐selectin, should be examined in these patients when quantifying BDNF. The gene discussed is PF4; the disease is major depressive disorder.